Literature DB >> 8835497

Experimental spondyloarthropathy in HLA-B27 transgenic rats.

J D Taurog1, R E Hammer.   

Abstract

Rats of the LEW, F344, and PVG strains bearing high copy numbers of transgenes for HLA-B27 and human beta 2-microglobulin develop a multisystem disorder, many features of which resemble aspects of the human spondyloarthropathies, most dramatically axial and peripheral arthropathy. The disease is not seen in rats with comparable expression of HLA-B7, and so is relatively specific for HLA-B27. It requires T cells and another bone marrow derived cell, as well as an intact gut flora. Characteristic cytokine profiles distinguish the inflammatory infiltrates in the gut and the joint, and the earliest T cell infiltrates at these sites are polyclonal. Polymorphism at the Tap-2 peptide transporter locus has no significant effect on disease, whereas the DA strain background abrogates disease. The molecular role of the B27 molecule in disease remains to be elucidated, but there is good reason to believe that it will eventually yield to continued investigation of this animal model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835497     DOI: 10.1007/bf03342640

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

2.  [Fusion of vertebrae and the sacroiliac joint by cartilaginous tissue in HLA-B27 transgenic rats].

Authors:  J Kriegsmann; B N Franklin; R E Gay; J D Taurog; R E Hammer; R Bräuer; D Katenkamp; S Gay
Journal:  Verh Dtsch Ges Pathol       Date:  1996

3.  A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology.

Authors:  H Mielants; E M Veys; S Goemaere; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

4.  Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease.

Authors:  W A Simmons; L Y Leong; N Satumtira; G W Butcher; J C Howard; J A Richardson; C A Slaughter; R E Hammer; J D Taurog
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

5.  Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

Authors:  J D Taurog; S D Maika; W A Simmons; M Breban; R E Hammer
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

6.  Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats.

Authors:  H Yanagisawa; J A Richardson; J D Taurog; R E Hammer
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

7.  T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.

Authors:  M Breban; J L Fernández-Sueiro; J A Richardson; R R Hadavand; S D Maika; R E Hammer; J D Taurog
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

8.  Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats.

Authors:  S Aiko; M B Grisham
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

9.  Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.

Authors:  M Breban; R E Hammer; J A Richardson; J D Taurog
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Seronegative spondyloarthropathies: to lump or split?

Authors:  P Nash; P J Mease; J Braun; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

2.  IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation.

Authors:  Monica Viladomiu; Charles Kivolowitz; Ahmed Abdulhamid; Belgin Dogan; Daniel Victorio; Jim G Castellanos; Viola Woo; Fei Teng; Nhan L Tran; Andrew Sczesnak; Christina Chai; Myunghoo Kim; Gretchen E Diehl; Nadim J Ajami; Joseph F Petrosino; Xi K Zhou; Sergio Schwartzman; Lisa A Mandl; Meira Abramowitz; Vinita Jacob; Brian Bosworth; Adam Steinlauf; Ellen J Scherl; Hsin-Jung Joyce Wu; Kenneth W Simpson; Randy S Longman
Journal:  Sci Transl Med       Date:  2017-02-08       Impact factor: 17.956

3.  Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis.

Authors:  Lotta Utriainen; Dawn Firmin; Pamela Wright; Vuk Cerovic; Maxime Breban; Iain McInnes; Simon Milling
Journal:  Arthritis Rheum       Date:  2012-10

4.  Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

Authors:  Adrian Cortes; Sara L Pulit; Paul J Leo; Jenny J Pointon; Philip C Robinson; Michael H Weisman; Michael Ward; Lianne S Gensler; Xiaodong Zhou; Henri-Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Linda A Bradbury; Dirk Elewaut; Ruben Burgos-Vargas; Simon Stebbings; Louise Appleton; Claire Farrah; Jonathan Lau; Nigil Haroon; Juan Mulero; Francisco J Blanco; Miguel A Gonzalez-Gay; C Lopez-Larrea; Paul Bowness; Karl Gaffney; Hill Gaston; Dafna D Gladman; Proton Rahman; Walter P Maksymowych; J Bart A Crusius; Irene E van der Horst-Bruinsma; Raphael Valle-Oñate; Consuelo Romero-Sánchez; Inger Myrnes Hansen; Fernando M Pimentel-Santos; Robert D Inman; Javier Martin; Maxime Breban; Bryan Paul Wordsworth; John D Reveille; David M Evans; Paul I W de Bakker; Matthew A Brown
Journal:  Nat Commun       Date:  2015-05-21       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.